Delivery Order SPE2DB22D2108-SPE2DB25FU3TU
- Not listed
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $1,970.57 and is a firm fixed-price delivery order with a completion date of March 19, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4,567,320 units of Ondansetron ODT 8 mg tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $2,154.60 and is a firm fixed-price delivery order, with a completion date of February 21, 2025. This contract is a part of a...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of Ondansetron ODT 8 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $11,505.68 and runs from March 2025 to March 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract award is for the delivery of ondansetron ODT 8 mg tablets, a medication used to treat nausea and vomiting. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $28,012.66 and an ultimate completion date of April 4, 2025. The contract is not designated with a set-aside. Amerisourcebergen...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of ondansetron ODT 8 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $4,589.93 and is a firm fixed-price type with an ultimate completion date of August 28, 2024. This contract award is not associated with a set-aside program. AmerisourceBergen, through its...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,300,001 units of ondansetron ODT 8 mg tablets, a medication used to treat nausea and vomiting. The contract is a firm fixed-price delivery order with a ceiling value of $4,349.64 and a period of performance through May 20, 2025. The contract does not have a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ondansetron ODT 8 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $6,024.00 and is a Firm Fixed Price Delivery Order with an ultimate completion date of April 2, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $8,294.76 and runs through May 31, 2024. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,503,318 units of 8 mg Ondansetron Orally Disintegrating Tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $15,505.38 and is a Firm Fixed Price Delivery Order, with a period of performance through March 10, 2025. The contract is not...
- This federal contract award, valued at $16,782.49, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,966,829 units of Ondansetron ODT 4 mg tablets, a medication used to treat nausea and vomiting. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 21, 2025. AmerisourceBergen Drug Corp holds a significant...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB25FU3TUDelivery Order
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of ondansetron ODT 8 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $10,996.87 and runs through March 10, 2025. It is a firm-fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.0k | 3/7/25 |